Correlation Between Adagene and AN2 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Adagene and AN2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adagene and AN2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adagene and AN2 Therapeutics, you can compare the effects of market volatilities on Adagene and AN2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adagene with a short position of AN2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adagene and AN2 Therapeutics.
Diversification Opportunities for Adagene and AN2 Therapeutics
0.07 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Adagene and AN2 is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Adagene and AN2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AN2 Therapeutics and Adagene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adagene are associated (or correlated) with AN2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AN2 Therapeutics has no effect on the direction of Adagene i.e., Adagene and AN2 Therapeutics go up and down completely randomly.
Pair Corralation between Adagene and AN2 Therapeutics
Given the investment horizon of 90 days Adagene is expected to under-perform the AN2 Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Adagene is 1.08 times less risky than AN2 Therapeutics. The stock trades about -0.22 of its potential returns per unit of risk. The AN2 Therapeutics is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest 110.00 in AN2 Therapeutics on August 28, 2024 and sell it today you would earn a total of 29.00 from holding AN2 Therapeutics or generate 26.36% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Adagene vs. AN2 Therapeutics
Performance |
| Timeline |
| Adagene |
| AN2 Therapeutics |
Adagene and AN2 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Adagene and AN2 Therapeutics
The main advantage of trading using opposite Adagene and AN2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adagene position performs unexpectedly, AN2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AN2 Therapeutics will offset losses from the drop in AN2 Therapeutics' long position.| Adagene vs. Eliem Therapeutics | Adagene vs. HCW Biologics | Adagene vs. Scpharmaceuticals | Adagene vs. Milestone Pharmaceuticals |
| AN2 Therapeutics vs. Aerovate Therapeutics | AN2 Therapeutics vs. Adagene | AN2 Therapeutics vs. Acrivon Therapeutics, Common | AN2 Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |